Key result
Prior treatment with EGCG (10, 20, and 30 mg/kg) for 21 days reduced the effects of isoprenaline on heart weight, cardiac marker enzymes, membrane-bound ATPases, and electrolytes in rats.
Why the study?
Does EGCG prevent isoprenaline-induced cardiac toxicity in Wistar rats?
Does EGCG prevent isoprenaline-induced cardiac toxicity in Wistar rats?
EGCG exhibits cardioprotective effects against isoprenaline-induced myocardial infarction in rats, likely due to its antioxidant and membrane-stabilizing properties.
No takes yet. Share an insight, caveat, or question.
EGCG attenuates isoprenaline effects in rats; leaves open translation to human myocardial injury without clinical trials.
Devika et al. (2007) studied Isoprenaline-induced myocardial infarction. (-)-epigallocatechin gallate (EGCG) vs. Isoprenaline alone was evaluated on Heart weight, cardiac marker enzymes, membrane-bound ATPases, and electrolytes. Prior treatment with EGCG (10, 20, and 30 mg/kg) for 21 days reduced the effects of isoprenaline on heart weight, cardiac marker enzymes, membrane-bound ATPases, and electrolytes in rats.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: